BRUKER CORPORATION Unrealized Gain (Loss) on Cash Flow Hedging Instruments
BRUKER CORPORATION (BRKR) reported Unrealized Gain (Loss) on Cash Flow Hedging Instruments of $105.00 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-03.
Financial Statements › Income Statement › Other Income
us-gaap:UnrealizedGainLossOnCashFlowHedgingInstruments · last filed 2025-03-03
- BRUKER CORPORATION unrealized gain (loss) on cash flow hedging instruments for fiscal 2024 was $105.00M.
- BRUKER CORPORATION unrealized gain (loss) on cash flow hedging instruments for fiscal 2023 was -$82.60M, a 224.02% decline from fiscal 2022.
- BRUKER CORPORATION unrealized gain (loss) on cash flow hedging instruments for fiscal 2022 was $66.60M.
| Period end | Unrealized Gain (Loss) on Cash Flow Hedging Instruments 12 month |
|---|---|
| 2024-12-31 | $105.00M 10-K · filed 2025-03-03 |
| 2023-12-31 | -$82.60M 10-K · filed 2025-03-03 |
| 2022-12-31 | $66.60M 10-K · filed 2025-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |